期刊文献+

世界基因治疗药物研发现状与我国发展对策

Global Research and Development Status of Gene Therapy Drug and Development Strategies of Our Country
原文传递
导出
摘要 近年来,随着基因治疗理论的发展和技术的进步,基因治疗药物研发取得了重大突破。我国在基因治疗药物的研发方面基本与发达国家同步,在产业化发展方面抢占了世界先机,具备较强的国际竞争力,但也面临着一些挑战。本文通过对世界基因治疗药物发展现状及其未来研发方向的分析探讨,提出了我国在基因治疗药物的研发过程中,应选择一些病种作为突破口,加强关键科学问题研究,鼓励协同创新与转化,建立健全政策法规和管理体系,促进我国基因治疗领域科技进步和产业有序、健康发展的建议。 In recent years,with the progress of science and technology on gene therapy,the research and development of gene therapy drug has made greats leaps forward. Although China has certain competitiveness on research and development of gene therapy drug,it is still faced with some restrictive factors. By analysis of the current situation and the prospects of future research of gene therapy drug in China and abroad,the paper puts forward some suggestions on the RD of gene therapy drug and its related industries of our country,such as selecting some diseases as breakthrough targets,tackling the key problems,encouraging collaborative innovation and transformation,and improving the policies and regulations and management system.
出处 《中国基础科学》 2015年第3期9-11,共3页 China Basic Science
关键词 基因治疗药物 协同创新 gene therapy drug collaborative innovation
  • 相关文献

参考文献10

  • 1Anderson W F, Blaese R M, Culver K, et al. The ADA human gene therapy clinical protocol: points to consider response with clinical protocol. Hum Gene Ther, 1990, 1:331-362.
  • 2Hacein-Bey-Abina S, Hauer J, Lira A, et al. Efficacy of gene thera- py for X-linked severe combined immunodeficiency. New EnglandJournal of Medicine, 2010, 363(4): 355-364.
  • 3Bainbridge J W B, Smith A J, Barker S S, et al. Effect of gene ther- apy on visual function in Leber's congenital amaurosis. New England Journal of Medicine, 2008, 358(21 ) : 2231-2239.
  • 4Maguire A M, Simonelli E, Pierce E A, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. New England Journal of Medicine, 2008, 358 (21) : 2240-2248.
  • 5Mitsuyasu R T, Merigan T C, Carr A, et al. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 + cells. Nature medicine, 2009, 15(3): 285-292.
  • 6Cartier N, Hacein-Bey-Abina S, Bartholomae C C, et al. Hematopoi- etic stem cell gene therapy with a lentiviral vector in X-linked adreno- leukodystrophy. Science, 2009, 326 (5954) : 818-823.
  • 7Naldini L. A comeback for gene therapy. Science, 2009, 326 (5954) : 805.
  • 8http://www, uniqure, com/news/227/182/uniQure-Announces-Re- suhs-for-the-Third-Quarter-of-2014, html.
  • 9Hsu P D, Lander E S, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014, 157 ( 6 ) : 1262-1278.
  • 10http ://www. wiley, co. uk/genetherapy/clinical/.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部